ORCID as entered in ROS

Select Publications
2021, 'ROUTINE OUTCOME MONITORING AND FEEDBACK IN SMART RECOVERY: FEASABILITY AND ACCEPTABILITY OF "SMART TRACK", AN INNOVATIVE, PURPOSE-BUILT SMART PHONE APP', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S23 - S24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200058&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'SYMPOSIUM: CONSUMER EXPERIENCES OF LONG-ACTING INJECTIBLE BUPRENORPHINE', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S17 - S18, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'EXPERIENCES AND EFFECTS OF EXTENDED-RELEASE BUPRENORPHINE DEPOT TREATMENT: QUALITATIVE FINDINGS FROM THE COLAB STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S18 - S18
,2019, 'BARRIERS AND FACILITATORS TO ENGAGING IN HEPATITIS C MANAGEMENT AND DIRECT-ACTING ANTIVIRAL THERAPY AMONG GENERAL PRACTITIONERS AND DRUG AND ALCOHOL SPECIALISTS: THE PRACTITIONER EXPERIENCE', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S9 - S9, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'PROMISE AND PHARMACEUTICALISATION IN THE ERA OF DIRECT-ACTING ANTIVIRALS', Montreal, Cananda, presented at International Symposium on Hepatitis Care in Substance Users, Montreal, Cananda, 11 September 2019 - 13 September 2019
,2018, 'Incidence of hepatitis C virus infection in four prisons in New South Wales, Australia: The SToP-C study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S187 - S188, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018, http://dx.doi.org/10.1016/S0168-8278(18)30587-7
,2017, 'Incidence of hepatitis C virus infection in two maximum-security prisons in New South Wales, Australia: the SToP-C study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S274 - S274, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)30862-0
,2016, 'Hepatitis C virus exposure, infection and associated risk behaviours in two maximum-security prisons in New South Wales, Australia', in HEPATOLOGY, WILEY, MA, Boston, pp. 385A - 386A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016
,2014, 'Understanding the Phases of Chronic Hepatitis B; the problem and a novel solution using renamed phases, the Hepatitis B Bear and a video (see " Understanding Hepatitis B " on YouTube)', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 1001A - 1002A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483804231&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Understanding the phases of chronic hepatitis B: the problem and a novel solution using renamed phases, the hepatitis B bear and a video (see "Understanding Hepatitis B" on YouTube)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 86 - 86, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000168&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, '"YOU'VE GOT CONTROL OF THE PUMP": THE IMPORTANCE OF TRUST IN THE DRUG TREATMENT CLINIC', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, pp. 3 - 4, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'UNDERSTANDING AND PREVENTING HEPATITIS C TRANSMISSION WITHIN SEXUAL PARTNERSHIPS', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, pp. 18 - 18, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'WORKSHOP - "CONSUMER PARTICIPATION IN DRUG TREATMENT SETTINGS - TREATMENT SERVICE USERS PROJECT - PHASE 2"', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL PUBLISHING, INC, pp. 46 - 47
,2009, 'EXPLORING THE ROLE OF CONSUMER PARTICIPATION IN DRUG TREATMENT', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL PUBLISHING, INC, pp. A5 - A5, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'KEY PRIORITIES IN HEPATITIS C: NEW INSIGHTS FROM SOCIAL RESEARCH', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL PUBLISHING, INC, pp. A71 - A72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300218&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'Alcohol and other drug treatment experiences of hepatitis C positive and hepatitis C negative clients: implications for the roll out of hepatitis C treatment', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A339 - A339, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000264953600017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'Hepatitis C treatment in pharmacotherapy services: increasing treatment uptake needs a critical view', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A338 - A339, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000264953600016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'What we do well – Stories of love, sex and relationship: a project looking at Aboriginal young people’s strengths and resources for building sexual well-being', Darwin, presented at LOWITJA HEALTH AND WELL-BEING CONFERENCE, Darwin, 18 June 2019 - 19 June 2019
,2018, 'Fostering the sexual well-being of Aboriginal young people by building on social, cultural and personal strengths and resources', Auckland, presented at IUSTI AP SEXUAL HEALTH CONGRESS 2018, Auckland, 01 November 2018 - 03 November 2018
,2017, 'Does Australia’s policy landscape support HCV treatment as prevention in the prison setting in the new DAA era?', New Jersey, USA, presented at 6th International Symposium on Hepatitis Care in Substance Users (INHSU), New Jersey, USA, 06 September 2017 - 08 September 2017
,2017, 'Scaling up or holding back? Contemplating treatment as prevention in the prison setting within Australia’s current policy frameworks.', Cairns, Queensland, presented at Australasian Viral Hepatitis Elimination Conference, Cairns, Queensland, 10 August 2017 - 11 August 2017
,2017, 'Treatment as prevention in the prison setting: Prisoners’ perspectives', presented at Australasian Viral Hepatitis Elimination Conference, 10 August 2017 - 11 August 2017
,2017, '“Behind closed doors, no one sees, no one knows”: Stigma and treatment as prevention in prison', Cairns, presented at Australasian Viral Hepatitis Elimination Conference, Cairns, 10 August 2017 - 11 August 2017
,2015, 'Identifying the social capital of men in prison screening positive for HCV', Hawaii, USA, presented at HEP DART 2015, Hawaii, USA, 06 December 2015 - 10 December 2015
,2015, 'Identifying the social capital of men in prison screening positive for HCV', Sydney, Australia, presented at 4th International Symposium on Hepatitis Care in Substance Users, Sydney, Australia, 07 October 2015 - 09 October 2015
,2015, '"It’s not only my life I got to worry about"’: accounts of needle-syringe sharing and negotiated safety among couples who inject drugs.', Manly, Sydney, presented at 4th International Symposium on Hepatitis Care in Substance Use, Manly, Sydney, 07 October 2015 - 09 October 2015
,2019, 'Understanding barriers and facilitators to the take up of new DAA hepatitis C treatments', presented at HARP Forum - 2019: The Millennial Edition, Sydney, 16 October 2019 - 17 October 2019
,2019, 'Injecting culture following prison-wide hepatitis c treatment scale-up: negotiating risk after cure', presented at Australasian Viral Hepatitis Elimination Conference, Sydney, Australia, 05 August 2019 - 06 August 2019
,2018, 'Reinfection and retreatment: Attitudes among prisoner participants from the Australian SToP-C study', presented at 7th International Symposium on Hepatitis Care in Substance Users, Cascais, Portugal, 19 September 2018 - 21 September 2018
,2018, 'The Matter of Reinfection: Attitudes among Australian Prisoners from the SToP-C Study', presented at Australasian Viral Hepatitis Conference 2018, Adelaide, 13 August 2018 - 15 August 2018
,2018, 'The National Stigma Indicator Project: Key findings and lessons regarding people living with HCV and people who inject drugs', presented at Australasian Viral Hepatitis Conference, Adelaide, 13 August 2018 - 15 August 2018
,2017, 'Prisoners' perspectives of treatment as prevention for hepatitis C in the prison setting', presented at HEP DART, Hawaii, USA, 03 December 2017 - 07 December 2017
,2017, 'Treatment as Prevention in the Prison Setting: Prisoners' Perspectives', presented at 6th International Symposium on Hepatitis Care in Substance Users (INHSU), New Jersey, USA, 06 September 2017 - 08 September 2017
,2017, 'A framework for hepatitis C virus treatment as prevention in the prison setting: the SToP-C implementation toolkit', presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31387-9
,2016, 'Development of a national monitoring system of stigma among people living with HIV in Australia', presented at Australasian HIV & AIDS Conference (26th Annual Conference of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine), Adelaide, 16 November 2016 - 18 November 2016
,2016, 'Improving STI/BBV testing and management in Aboriginal community controlled health services: A systematic review of what works, what doesn’t', presented at 2017 Australasian HIV & AIDS Conference, Adelaide, 14 November 2016 - 16 November 2016
,2016, 'Preparing Prescription Opiates for Injection: Understanding Preferences and Practices', presented at Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Sydney, Australia, 30 October 2016 - 02 November 2016
,2016, 'Relationships Matter: Social capital theory and the delivery of hepatitis C treatment in prison', presented at 10th Australasian Viral Hepatitis Conference, Gold Coast, Australia, 29 September 2016 - 01 October 2016
,2016, 'Stigma among people living with hepatitis C and people who inject drugs in Australia', presented at 10th Australasian Viral Hepatitis Conference, Gold Coast, 29 September 2016 - 01 October 2016
,2016, 'Utilising social capital to promote HCV treatment in prison', presented at 5th International Symposium on Hepatitis Care in Substance Users (INHSU), Oslo, Norway, 07 September 2016 - 09 September 2016
,2016, 'Building social capital to promote HCV treatment in prison', presented at National Hepatitis Health Promotion Conference, Melbourne, Australia, 19 May 2016 - 20 May 2016
,2016, 'Development of a brief indicator of stigma among people living with blood borne viruses and sexually transmitted infections in Australia', presented at 14th Social Research Conference on HIV, Viral Hepatitis and Related Diseases, Sydney, 31 March 2016 - 01 April 2016
,2016, 'Exploring dimensions of social capital of men in prison living with hepatitis C', presented at Social Research Conference on HIV, Viral Hepatitis and Related Diseases, 31 March 2016 - 01 April 2016
,2016, ''I’m always going to be with you, so don’t worry': Accounts of changing hepatitis C serostatus among couples who inject drugs', presented at 14th Social Research Conference on HIV, Viral Hepatitis and Related Diseases, Sydney, 31 March 2016 - 01 April 2016
,2016, '‘He’s the only person I’ll share with': Accounts of needle-syringe sharing and negotiated safety among couples who inject drugs', presented at 14th Social Research Conference on HIV, Viral Hepatitis and Related Diseases, Sydney, 31 March 2016 - 01 April 2016
,2016, '“She’s my wife and men are just sex”: Compartmentalisation and wellbeing among married men who have sex with men', presented at 14th Social Research Conference on HIV, Viral Hepatitis and Related Diseases, Sydney, 31 March 2016 - 01 April 2016
,2015, '‘It’s not only my life I got to worry about’: Accounts of needle-syringe sharing and negotiated safety among couples who inject drugs.', presented at 4th International Symposium on Hepatitis Care in Substance Use, Manly, Sydney, 07 October 2015 - 09 October 2015
,2014, 'Negotiating risk, navigating relationship: accounts of needle-syringe sharing within romantic partnerships.', presented at 9th Australasian Viral Hepatitis Conference, Alice Springs, 17 September 2014 - 19 September 2014
,2014, '“You’ve Got Control Of The Pump”: The Importance Of Trust In The Drug Treatment Clinic. [invited plenary]', presented at Network of Alcohol and Drug Agencies (NADA) Conference, Sydney, 12 May 2014 - 13 May 2014
,2014, '“You’ve Got Control Of The Pump”: The Importance Of Trust In The Drug Treatment Clinic. [invited plenary]', presented at Alcohol, Tobacco and Other Drugs Council (ATDC) Conference, Hobart, 07 May 2014 - 08 May 2014
,